首页 正文

AB-Amy: machine learning aided amyloidogenic risk prediction of therapeutic antibody light chains

{{output}}
Over 120 FDA-approved antibody-based therapeutics are used to treat a variety of diseases.However, many candidates could fail because of unfavorable physicochemical properties. Light-chain amyloidosis is one form of aggregation that can lead to severe safety r... ...